Montelukast formulation to be tested in Swedish Parkinson’s study
IntelGenx has finalized a research grant agreement with Karolinska University Hospital, Sweden for a placebo-controlled clinical study of Montelukast…
Articles by Margarida Maia, PhD
‘Young’ transplanted stem cell neurons ease symptoms in rats
Skin cells from people with Parkinson’s disease were transformed into stem cells that could generate dopamine-producing neurons, the same…
Sensor chip offers better way of diagnosing, monitoring Parkinson’s
A sensor chip that can distinguish harmless single units of proteins tied to diseases like Parkinson’s from those whose…
Dopamine agonists appear least likely to cause dyskinesia, off times
Among available dopamine agonists to treat early Parkinson’s disease, ropinirole is the least likely to cause dyskinesia, the…
Gaps in US healthcare bigger for certain Parkinson’s patients: Study
Gaps in healthcare for individuals with Parkinson’s disease in the U.S. have been identified, with notable disparities observed for…
Improved software for deep brain stimulation wins FDA approval
The U.S. Food and Drug Administration (FDA) has approved Boston Scientific’s software called Vercise Neural Navigator 5, which provides visual…
Imaging software focusing on white matter may aid Parkinson’s diagnosis
Imaging software developed by Braintale may distinguish Parkinson’s disease from atypical parkinsonism based on measures of…
A smartwatch may ID Parkinson’s up to 7 years before symptoms seen
Using a smartwatch to track how fast people can move may help identify who’s at risk for Parkinson’s disease…
UC Davis Health joins Parkinson’s Foundation Center of Excellence
The Center for Movement Disorders and Neurorestoration at the University of California (UC) Davis Health Department of Neurology will…
BrainTale raises €4.5M to develop brain-decoding software
BrainTale raised €4.5 million (about $5 million) to speed further development of software that can decode changes in the…